ClinVar Miner

Submissions for variant NM_000135.4(FANCA):c.3624C>T (p.Ser1208=) (rs149797103)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000479566 SCV000567385 uncertain significance not provided 2017-02-21 criteria provided, single submitter clinical testing The c.3624 C>T variant in the FANCA gene has been reported previously in the heterozygous state in patients with Fanconi anemia who were also heterozygous for a second FANCA variant, however, additional clinical and familial segregation information were not included (Gille et al., 2012; Ameziane et al., 2008). This splice site variant destroys the natural splice donor site and creates a cryptic splice donor site in exon 36, and is expected to cause abnormal gene splicing. The c.3624 C>T variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret c.3624 C>T as a variant of uncertain significance.
Genetic Services Laboratory, University of Chicago RCV000500885 SCV000594652 likely pathogenic Fanconi anemia, complementation group A 2016-11-11 criteria provided, single submitter clinical testing
Invitae RCV000813304 SCV000953661 likely pathogenic Fanconi anemia 2018-08-01 criteria provided, single submitter clinical testing This sequence change affects codon 1208 of the FANCA mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the FANCA protein. This variant is present in population databases (rs149797103, ExAC 0.07%). This variant has been observed in several individuals affected with Fanconi anemia (PMID: 29098742, 17924555, 22778927). ClinVar contains an entry for this variant (Variation ID: 419528). Experimental studies have shown that this change results in aberrant splicing (PMID: 17924555). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.